Literature DB >> 15551279

Pericardial effusion: a rare presentation of adult T-cell leukemia/lymphoma.

Fernando P Chaves1, Karen Quillen, Dongsheng Xu.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) has a wide variety of clinical presentations. The most common ones include leukemia, hypercalcemia, lymphadenopathy, hepatosplenomegaly, and skin lesions. We report a case of ATLL in a 73-year-old woman who presented initially with chest discomfort and shortness of breath. The patient had no peripheral lymphadenopathy, circulating lymphoma cells, hepatosplenomegaly, or skin lesions. CT scan showed small mediastinal lymph nodes and pericardial effusion. Diagnosis was established by cytomorphologic evaluation and flow cytometric analysis of the pericardial fluid. Cardiac involvement is a rare event in ATLL and, when present, usually is a late finding in the setting of disseminated disease. This case was unusual because the patient lacked all common clinical features of ATLL. We present this case so as to increase awareness that ATLL could initially present with pericardial effusion. The pathophysiologic mechanisms of cardiac involvement are also discussed. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15551279     DOI: 10.1002/ajh.20229

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Cardiac Involvement of Adult T Cell Leukemia/Lymphoma.

Authors:  Makoto Yoshimitsu; Katsunori Tofuku; Daisuke Ikeda; Nobuhito Ohno; Kenji Ishitsuka; Hidetoshi Nakashima
Journal:  Intern Med       Date:  2021-09-18       Impact factor: 1.282

2.  Clinical features of cardiac lymphoma: an analysis of 37 cases.

Authors:  Yu Zhao; Sai Huang; Chao Ma; Haiyan Zhu; Jian Bo
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

3.  Pericardial effusion and atrial thrombosis: a rare complication of childhood leukemia.

Authors:  Soheila Zareifar; Sirous Cheriki; Maral Namdari; Mohammadreza Farahmandfar; Ahmad Jannati
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

Review 4.  Serous fluids and hematolymphoid disorders.

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.